Format

Send to

Choose Destination
Therapie. 2011 Jan-Feb;66(1):39-44. Epub 2011 Apr 7.

[Level of evidence for therapeutic drug monitoring of aminoglycosides].

[Article in French]

Author information

1
Service de Toxicologie et Pharmacocinétique, CHU, Poitiers, France. n.venisse@chu--poitiers.fr

Abstract

Aminoglycosides are major antibiotics indicated for the treatment of infection with gram-negative bacilli. They are characterized by high clinical effectiveness but their main drawback is the occurrence of toxicity in a significant number of patients. Pharmacokinetic parameters of aminoglycosides exhibit wide inter-individual variability and the relationships between concentration and effect have been clearly demonstrated. Consistent studies have demonstrated that therapeutic drug monitoring (TDM) of aminoglycosides administered in multiple daily doses was cost-effective in maximising antibiotic efficacy and/or reducing incidence of toxicity. Therefore TDM of aminoglycosides should be considered "essential". Level of evidence for TDM of aminoglycosides administered once daily is not so clearly demonstrated however it should be highly recommended.

PMID:
21466776
DOI:
10.2515/therapie/2011001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for EDP Sciences
Loading ...
Support Center